POINT Biopharma USA Inc.

Form 483FOIA Uncovered

Issued June 07, 2024

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

ObservationsNot available

Issue DateJune 07, 2024

StatusNo Warning Letter

Related Inspections0

Establishment Details

Firm: POINT Biopharma USA Inc.
Location: N/A
FEI Number: N/A
Issue Date: June 07, 2024
Country: N/A

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

POINT Biopharma USA Inc. FDA Form 483, June 7, 2024